NCI's Office of Data Sharing Annual Symposium (Speaker Bios)

Speaker Bios

 

  • Caitlyn Barrett
    Caitlyn Barrett, Ph.D.
    Science & Innovation Lead, SEE RARE

    Caitlyn Barrett, PhD, is the Science & Innovation Lead at SEE RARE. She leads SEE RARE’s innovation agenda, including its public indices tracking how rare diseases are diagnosed, funded, and treated.

    Caitlyn has spent her career working where science, philanthropy, and patient advocacy meet. Most recently, she was a director with the Science Philanthropy Accelerator for Research and Collaboration (SPARC) at the Milken Institute. There, she helped philanthropists invest strategically in biomedical research, oversaw more than $150 million in investments, and led landscape reports and expert convenings across rare disease, oncology, and neurodegeneration. Before Milken, she was Senior Director of Research and Programs at CureSearch for Children’s Cancer. In that role, she managed the organization’s research grant portfolio and connected pediatric cancer researchers with donors, advocates, and partners. Earlier, she was a Program Manager in the National Cancer Institute’s Office of Cancer Genomics.

    Caitlyn is Vice Chair of the Board of Directors of the Coalition Against Childhood Cancer. She holds a PhD in Cancer Biology from Vanderbilt University. She completed postdoctoral training at the University of Pittsburgh’s Pittsburgh Institute for Neurodegenerative Diseases.

  • Mary Charlton
    Mary Charlton, Ph.D.
    Professor, University of Iowa

    Dr. Charlton is a Professor in the Department of Epidemiology at the University of Iowa College of Public Health and Director of the Iowa Cancer Registry. She is also the Past President of the Iowa Cancer Consortium and Co-Leader of the Cancer Prevention, Control and Survivorship Program at the Holden Comprehensive Cancer Center. Her research focuses on cancer surveillance and on improving access and quality of cancer care for rural populations.

  • Caroline Chung
    Caroline Chung, M.D.
    Co-Director of the Institute for Data Science in Oncology, University of Texas MD Anderson Cancer Center

    Dr. Chung is co-director of the Institute for Data Science in Oncology and tenured Professor of Radiation Oncology and Diagnostic Imaging at The University of Texas MD Anderson Cancer Center and also served the inaugural vice president Chief Data & Analytics Officer of UT MD Anderson Cancer Center. She is a clinician-researcher with a computational imaging lab focused on quantitative imaging and modeling to optimize personalized, adaptive treatment for cancer patients. Across
    her career she has worked with industry on co-development of technology through to FDA approval and clinical implementation, establishing multiple academic-industry partnerships and serving as an advisor to start ups through the TMC Innovation accelerator. Internationally, Dr. Chung is a recognized thought leader across data
    governance, data science, AI and digital twins. This includes her leadership of the biomedical team for the National Academies of Sciences, Engineering, and Medicine (NASEM)-appointed committee addressing Foundational Research Gaps and Future Directions for Digital Twins, serving as co-chair of the American Society of Clinical Oncology (ASCO) AI Community of Practice, co-chair of the Quantitative Imaging for Assessment of Response in Oncology Report Committee of the International commission on Radiation Units and Measurements, member of the American Association for Cancer Research (AACR) Data Science Taskforce and the ESMO AI and Digital Oncology Committee, as well as a member of the Forbes Tech Council. Most recently she has been named among the Top 50 Women leaders in Houston in 2026, named by Reuters as one of the 2026 Trailblazing Women in Enterprise AI, included among CDO Magazine Top 30 Healthcare Innovators 2026, and recognized with AI150's AI for Health Impact Award.

  • Theodore Feldman
    Theodore Feldman, Ph.D.
    Investigator, Data Scientist, Boston Veterans Affairs

    Theodore (Ted) Feldman, Ph.D. is an investigator and data scientist at the CSP Informatics Center withing the VA Boston Healthcare System. His research focuses on the progression on the application of machine learning to clinical questions and clinical decision support in the progression of chronic diseases to cancers of the liver and biliary tree, the expanded interpretation and use of clinical genomic sequencing and our understanding of the relationship between military-occupational exposures and carcinogenesis. Ted also contributes to operational efforts including the expanded sharing de-identified VA data through the Veterans Precision Oncology Data Commons and applications to facilitate patient-to-trial-matching, including several NCI-VA oncology trials. Ted is recipient of a VA Career Development Award. Ted has mentored/co-mentored several post-docs who now have permanent positions within the VA and in industry. In a teaching capacity, Ted serves as a Master’s Thesis Advisory Committee Chair within the Department of Biomedical Informatics at Harvard Medical School. He was a 2018 – 2019 VA NCI Big Data Scientist Training Enhancement Program (BD-STEP) Fellow, an HMS Curriculum Fellow from 2015 - 2018 and received his Ph.D. in Applied Physics with a specialization in Molecular Biophysics from Harvard University in 2015. Ted earned simultaneous B.E. in Engineering Science (Specialization in Materials Science and Engineering and B.S. Physics degrees at Stony Brook University after and during which his research experiences included work at the National Ignition Facility at Lawrence Livermore National Lab and an NIH-sponsored summer fellowship at the National Synchrotron Light Source, Brookhaven National Laboratory.

  • Alan Hutson
    Alan D. Hutson, Ph.D.
    Professor and Chair, Roswell Park Comprehensive Cancer Center

    Dr. Alan Hutson is Chair of Biostatistics and Bioinformatics at Roswell Park Comprehensive Cancer Center. He earned his B.A. (1988) and M.A. (1990) in Statistics from the State University of New York at Buffalo and worked as a biostatistician at Otsuka America Pharmaceuticals before completing his M.A. (1993) and Ph.D. (1996) in Statistics at the University of Rochester.

    Dr. Hutson began his academic career at the University of Florida in 1996, where he advanced to Associate Professor and held leadership roles including Interim Director of the Division of Biostatistics and Director of the General Clinical Research Informatics Core. In 2002, he joined the University at Buffalo as Associate Professor and Chief of the Division of Biostatistics. He became the founding Chair of the Department of Biostatistics in 2003 and was promoted to Professor in 2007.

    Since joining Roswell Park in 2005, Dr. Hutson has led major initiatives in biostatistics, bioinformatics, and biomedical research informatics. He is a Professor of Oncology, a NYSTAR Distinguished Professor, and a Fellow of the American Statistical Association. He serves as Associate Editor of Communications in Statistics and on the editorial board of Cancers.

    Dr. Hutson's research focuses on nonparametric statistical methods and clinical trial design. He has authored more than 300 peer-reviewed publications and two monographs and has served on numerous data safety monitoring boards and scientific review panels. He is the contact MPI for the NCI-funded CIP-Net, ARTNet, and CAP-IT coordinating centers and co-chairs their steering committees. He also served as the inaugural Chair of the Society for Immunotherapy of Cancer (SITC) Data Sharing and Big Data Committee.

  • Xuelu (Jeff) Liu
    Xuelu (Jeff) Liu
    Director, Data Management & Strategy, Dana-Farber Cancer Institute

    Xuelu (Jeff) Liu is Director of Data Management & Strategy in the Division of Population Sciences at Dana-Farber Cancer Institute, with over 17 years of experience building and streamlining data and analytics workflows for biomedical research and precision oncology. He leads data strategy and informatics initiatives that advance FAIR data practices, promote data sharing, support cohort discovery and outcomes research, and strengthen multimodal cancer research data integration. His work includes launching Dana-Farber’s institutional cancer research data gateway and catalog, operationalizing LLM-powered cohort querying and aggregation, leading development of an enterprise molecular data ecosystem for precision oncology, and supporting clinical trials through REDCap data pipeline automation. He also provides institutional data engineering leadership for Cancer AI Alliance (CAIA) projects, including federated learning approaches that support privacy-preserving, multi-institutional AI collaboration. His recent cancer AI proposals were awarded $130,000 in cloud credits from Google and CAIA.
    Prior to joining Dana-Farber, He worked 8 years at the NIH’s Center of Information Technology (CIT) in supporting lymphoma research and building the enterprise data platform-the Biomedical Research Informatics Computing System (BRICS). His multidisciplinary background spans veterinary medicine science, quantitative genetics, and computer science. He also completed the 2025 NIH AIM-AHEAD program in machine learning and equitable AI.

  • Patrick Newbold
    Patrick Newbold
    Chief Information Officer, Centers for Medicare & Medicaid Services

    Patrick Newbold is the Chief Information Officer (CIO) for the Centers for Medicare & Medicaid Services (CMS) and Director of the Office of Information Technology, where he leads the technology strategy and operations supporting one of the largest and most complex healthcare enterprises in the world. In this role, he is responsible for aligning technology, cybersecurity, and digital services with CMS’s mission to serve millions of beneficiaries, providers, and partners nationwide.


    Patrick brings a distinguished record of senior federal leadership spanning healthcare, space, and defense. Prior to joining CMS, he served at the National Aeronautics and Space Administration (NASA) as Deputy CIO for Strategy, overseeing enterprise IT strategy, business operations, and customer engagement. He previously held senior leadership roles at the Social Security Administration (SSA), including Chief Information Officer, where he was the agency’s most senior technology executive responsible for information technology, software engineering, and cybersecurity risk management and operations. At SSA, he also co-founded the Office of Transformation and helped drive agency-wide digital modernization efforts focused on improving service delivery and organizational performance.

    Across his career, Patrick has been a consistent advocate for modernizing government through practical, mission-driven use of technology, strengthening digital services, improving resilience and security, and enabling better outcomes through data and innovation. Since 2023, Patrick has served on the Technology Modernization Fund (TMF) Board, where he helps evaluate and guide federal agency modernization proposals under the Modernizing Government Technology Act.

  • Corrie Painter
    Corrie Painter, Ph.D.
    Partner, Even One Ventures

    Corrie Painter, PhD, is a Partner at Even One Ventures, where she builds companies focused on personalized medicines and technologies. She brings experience as a cancer research scientist, biotech operator, and patient advocate. At the Broad Institute, she helped build a national patient-partnered clinico-genomic data platform and led efforts to openly share those data to accelerate discovery. She later helped build Precede Biosciences from its earliest days through its Series B financing, working across translational science, partnerships, and company building.
    Painter earned her PhD in biochemistry and trained in cancer immunology. She is an angiosarcoma survivor and co-founder and President of Angiosarcoma Awareness, where she works to accelerate research and expand options for patients with rare cancers.

  • Vasum Peiris
    Vasum Peiris, M.D., M.P.H., FAAP, FACC, FASE
    Pediatric Physician, Children’s National Hospital

    Vasum Peiris, MD, MPH, FAAP, FACC, FASE, is a physician, healthcare executive, and strategic advisor whose work connects clinical medicine, scientific evidence, and public policy to advance health innovation. He served for a decade as Chief Medical Officer and Associate Director for Pediatrics and Special Populations at the FDA’s Center for Devices and Radiological Health, helping shape initiatives in digital health, artificial intelligence, real-world evidence, and medical device development. His work brings together government, academia, industry, and patient communities to address barriers to innovation and access.
    A pediatric and adult congenital cardiologist, Dr. Peiris previously served as Chief of Pediatric and Adult Congenital Cardiology and held the Joon Park M.D. Endowed Chair in Medical Excellence at Texas Tech University Health Sciences Center and University Medical Center. He also helped lay the foundation for what is now TTUHSC’s Julia Jones Matthews School of Population and Public Health, providing a unique focus in rural healthcare.
    Dr. Peiris maintains clinical service at Children’s National Hospital with academic appointment at Professor (adjunct) at the George Washington University School of Medicine and Health Sciences. His education and clinical training span Yale College, Yale School of Medicine, The University of Vermont College of Medicine, and Harvard Medical School.

  • Kelli  Rasmussen
    Kelli M Rasmussen, MS
    Associate Director, Project GENIE, American Association for Cancer Research

    Kelli M. Rasmussen, MS, is Associate Director of AACR Project GENIE, an international data-sharing initiative that brings together real-world clinical and genomic data to advance precision oncology. She helps lead the Project GENIE Coordinating Center, guiding operations, cross-institutional collaboration, data model development, and efforts to make complex oncology data more standardized, accessible, and useful for research.

    Rasmussen has more than a decade of experience spanning cancer epidemiology, real-world evidence, data science, and research operations. Before joining the American Association for Cancer Research, she served as a senior data scientist in the University of Utah’s Division of Epidemiology and worked with the Veterans Health Administration on large-scale oncology research and cancer-care coordination initiatives, including the VetConnect Cancer Navigator. Her research has examined treatment patterns, outcomes, disparities, and data resources across multiple cancer populations.

    She holds a Master of Science in sociology with an emphasis in population health sciences from the University of Utah. Her work focuses on transforming heterogeneous real-world cancer data into reusable evidence through thoughtful data standards, transparent methods, and multidisciplinary collaboration.

  • Johnie Rose
    Johnie Rose, M.D., Ph.D
    Associate Professor / Director, Case Comprehensive Cancer Center Population Cancer Analytics Shared Resource, Case Comprehensive Cancer Center

    Johnie Rose, MD, PhD is a Preventive Medicine and Public Health physician and epidemiologist specializing in the study of population health determinants and outcomes in cancer. He serves as Associate Professor in the Center for Community Health Integration at Case Western Reserve University School of Medicine and directs the Case Comprehensive Cancer Center Population Cancer Analytics Shared Resource. His research and methodological work involve development of computer simulation models of interventions in populations, leveraging secondary data sources to drive population health research and intervention, applying data science tools to population health data, and conducting health economic analyses. In addition to his research, he frequently speaks on the topics of health systems, health policy, and health care reform.

  • Stephan Schürer
    Stephan Schürer, Ph.D.
    Professor; Associate Director, Data Science, University of Miami; Sylvester Comprehensive Cancer Center

    Stephan Schürer, PhD, is a Professor of Pharmacology at the University of Miami, Associate Director of Data Science at the Sylvester Comprehensive Cancer Center, and Director of Digital Drug Discovery at the Frost Institute for Data Science & Computing. His research bridges data science, chemistry, biology, and medicine to drive AI-enabled drug discovery, precision oncology, and translational research informatics.
    Dr. Schürer earned his PhD in chemistry from the Technical University of Berlin and held leadership roles in biotech startups in Silicon Valley before joining Scripps Florida to lead discovery informatics for the NIH Molecular Libraries Program. At Miami, he developed the widely adopted BioAssay Ontology (BAO) and has served as Principal Investigator in multiple national initiatives, including LINCS, IDG, BD2K, RADx, and MorPhiC.
    His lab, the Systems Drug Discovery Group, develops scalable data infrastructure and AI tools to support drug repurposing, small-molecule discovery for understudied targets, and precision combination therapies. The team builds full-stack applications and FAIR data platforms that integrate research and clinical datasets to support collaborative, translational biomedical research.
    At the Sylvester Comprehensive Cancer Center, his team develops the Sylvester Data Portal, a multimodal, AI-enabled research informatics platform that supports the secure, scalable integration, management, and analysis of cancer research, clinical, molecular, and clinicogenomic data.

  • Ben Vandendriessche
    Ben Vandendriessche, Ph.D.
    President and Chief Scientific Officer , Digital Medicine Society

    Benjamin (Ben) Vandendriessche is President and Chief Scientific Officer (CSO) at the Digital Medicine Society (DiMe), dedicated to advancing digital medicine to optimize human health. He has more than a decade of experience in the development of and market access paths for digital health technologies in the US and EU, and their medical applications in research and delivery of care. Previously, Ben was Chief Medical Officer at health tech startup Byteflies, which developed and deployed a remote patient monitoring platform for clinical trials and virtual care applications.
    He trained in molecular biology, systems physiology, and data analytics for vital sign processing. He completed a PhD in Molecular Biology at Ghent University as an IWT Fellow, followed by a postdoc on the interface of Critical Care Medicine and Computer Science at Case Western Reserve University (CWRU) as a BAEF Fellow. He holds an adjunct assistant professor position at CWRU and publishes regularly on all things digital medicine.

  • Satish Viswanath
    Satish E Viswanath, PhD
    Associate Professor, Emory University

    I am a tenured Associate Professor in the Departments of Pediatrics and Biomedical Engineering at Emory University, with secondary appointments in the Department of Biomedical Informatics. I am also a Research Biomedical Engineer at the Atlanta VA Medical Center. I have authored over 60 peer-reviewed journal publications, 120+ conference papers & abstracts, 1 book chapter, as well as delivered over 100 invited talks and panel discussions both in the US and abroad. I have 10 issued patents in the areas of medical image analysis, computer-aided diagnosis, and pattern recognition. I am an Associate Editor or Editorial Board Member for 9 leading international peer-reviewed journals, serve as Program Committee Member or Area Chair for 3 major medical imaging conferences, and have been elected to Senior Member in the National Academy of Inventors, the IEEE, and the SPIE. Recognition for my work includes the Fulbright Specialist Award, in addition to multiple awards from SIIM, SPIE, and Crain’s Cleveland Business. My lab’s research has received funding from federal and state agencies including the DOD/CDMRP, the VA, the NIH (NCI, NIBIB, NINR, NHLBI), as well as private foundations.

  • Jeremy Warner
    Jeremy Warner, M.D.
    Professor of Biostatistics, Professor of Medicine, Brown University

    Jeremy L. Warner MD, MS, FAMIA, FASCO is a Professor of Medicine and Professor of Biostatistics at Brown University, the Associate Director of Data Science at the Legorreta Cancer Center at Brown University, and an attending physician at the Brown University Health Cancer Institute. Dr. Warner's clinical focus is malignant hematology and he is the Editor-in-Chief of JCO Clinical Cancer Informatics. His primary research goal is to make sense of the structured and unstructured data present in electronic health records (EHRs) and clinical knowledge bases, and he has published over 180 manuscripts in these areas. He is the Chief Technology Officer of HemOnc.org, where he oversees the development and maintenance of the HemOncKB, an ontology and knowledge base focused on capturing all relevant knowledge pertinent to chemotherapy drugs and regimens. In March 2020 he co-founded the COVID-19 and Cancer Consortium (CCC19) and is the Director of its Research Coordinating Center. He is a standing member of the Clinical Data Management and Analysis (CDMA) NIH Study Section. He is the founding Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS) of the Legorreta Cancer Center.

  • Carrie Wright
    Carrie Wright, Ph.D.
    Senior Staff Scientist, Fred Hutchinson Cancer Center

    Carrie is a Senior Staff Scientist in the Biostatistics Program of the Public Health Sciences Division at Fred Hutchinson Cancer Center. Her work focuses on developing methods, tools, and educational resources that make data science more accessible to researchers, enabling them to work with data more rigorously, reproducibly, and ethically. She leads and contributes to initiatives such as the Informatics Technology for Cancer Research Training Network (ITN) (https://www.itcrtraining.org) and Open Case Studies (https://www.opencasestudies.org). She also explores how scientists conduct research and use AI in research, with a focus on scientific integrity, reproducibility, and mentorship.